Subthreshold opioid use disorder prevention trial (CTN-0101). August 1, 2024 to march 31, 2026. N01DA-22-2253. Task order no. 75N95024F00004 (TO20).
Ended Awarded
- Contract number
- 75N95024F00004
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $113,621
Award facts
- Opportunity
-
- 75N95024F00004 Solicitation number
- Contract value 100% obligated
- $113,621.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA) to The Emmes Company LLC, a global clinical research organization. The contract supports the "Subthreshold Opioid Use Disorder Prevention Trial" (CTN-0101) for the period of August 1, 2024 to March 31, 2026. The total ceiling value of the contract is $113,621.00. This contract is not set aside for any specific business type.
The Emmes Company LLC is an experienced provider of services to NIDA and other National Institutes of Health (NIH) institutes, including data management, statistical analysis, clinical trial coordination, regulatory support, and operational oversight for research programs. The company holds several significant Indefinite Delivery Vehicles (IDVs) with NIDA and other NIH institutes, which facilitate the provision of these specialized services across multiple research initiatives.
Quick answers
Who was awarded contract 75N95024F00004?
75N95024F00004 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2024.
How much is contract 75N95024F00004 worth?
The government has obligated $113,621 on 75N95024F00004.
Is contract 75N95024F00004 an order under another contract?
Yes. 75N95024F00004 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95024F00004 competed?
The extent of competition for 75N95024F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award